Active Ingredient: ERYTHROMYCIN ESTOLATE
Proprietary Name: ILOSONE
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: EQ 125MG BASE/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050010
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LILLY RESEARCH LABORATORIES DIV ELI LILLY AND CO
Marketing Status:
Discontinued
Patent and Exclusivity Information
